142 related articles for article (PubMed ID: 10775054)
1. The expression of common fragile sites in peripheral blood lymphocytes of breast and colorectal cancer patients with aphidicolin.
Balci A; Ekmekci A; Cetin R
Tohoku J Exp Med; 1999 Oct; 189(2):107-16. PubMed ID: 10775054
[TBL] [Abstract][Full Text] [Related]
2. The expression frequency of common fragile sites and genetic predisposition to colon cancer.
Tunca B; Egeli U; Zorluoglu A; Yilmazlar T; Yerci O; Kizil A
Cancer Genet Cytogenet; 2000 Jun; 119(2):139-45. PubMed ID: 10867150
[TBL] [Abstract][Full Text] [Related]
3. Expression of aphidicolin-induced fragile sites in lymphocytes of patients with breast cancer.
Ardisia C; Venti G; Colozza MA; Breschi C; Porfirio B; Davis S; Tonato M; Donti E
Cancer Genet Cytogenet; 1993 Jun; 67(2):113-6. PubMed ID: 8330266
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous unusual expression of frequency of chromosome aberrations and common fragile in human lymphocytes of colorectal cancer patients induced by Aphidicolin.
Saxena AK; Agarwal CS; Kumar M; Srivastava AK; Singh G
J Exp Ther Oncol; 2007; 6(2):175-9. PubMed ID: 17407975
[TBL] [Abstract][Full Text] [Related]
5. Common fragile site expression and genetic predisposition to breast cancer.
Ceçener G; Egeli U; Taşdelen I; Tunca B; Duman H; Kizil A
Teratog Carcinog Mutagen; 1998; 18(6):279-91. PubMed ID: 10052563
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast-specific common fragile sites induced by aphidicolin.
Murano I; Kuwano A; Kajii T
Hum Genet; 1989 Aug; 83(1):45-8. PubMed ID: 2504659
[TBL] [Abstract][Full Text] [Related]
7. The expression of aphidicolin-induced fragile sites in familial breast cancer patients.
Mitchell EL; Woodhouse B; Birch JM; Santibanez-Koref MF
Cancer Genet Cytogenet; 1993 Jun; 67(2):108-12. PubMed ID: 8392434
[TBL] [Abstract][Full Text] [Related]
8. DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes.
Glover TW; Berger C; Coyle J; Echo B
Hum Genet; 1984; 67(2):136-42. PubMed ID: 6430783
[TBL] [Abstract][Full Text] [Related]
9. Expression of common fragile sites in untreated non-Hodgkin's lymphoma with aphidicolin and folate deficiency.
Chary-Reddy S; Prasad VS; Ahuja YR
Cancer Lett; 1994 Oct; 86(1):111-7. PubMed ID: 7954347
[TBL] [Abstract][Full Text] [Related]
10. Expression of aphidicolin-induced fragile sites and their relationship between genetic susceptibility in breast cancer, ovarian cancer, and non-small-cell lung cancer patients.
Dhillon VS; Husain SA; Ray GN
Teratog Carcinog Mutagen; 2003; Suppl 1():35-45. PubMed ID: 12616595
[TBL] [Abstract][Full Text] [Related]
11. Fragile sites in human and Macaca fascicularis chromosomes are breakpoints in chromosome evolution.
Ruiz-Herrera A; Ponsà M; García F; Egozcue J; García M
Chromosome Res; 2002; 10(1):33-44. PubMed ID: 11863068
[TBL] [Abstract][Full Text] [Related]
12. Common fragile sites: their prevalence in subjects with constitutional and acquired chromosomal instability.
Tedeschi B; Porfirio B; Vernole P; Caporossi D; Dallapiccola B; Nicoletti B
Am J Med Genet; 1987 Jun; 27(2):471-82. PubMed ID: 3111262
[TBL] [Abstract][Full Text] [Related]
13. Expression of folate sensitive and aphidicolin induced chromosomal fragile sites in familial neuroblastoma.
Ankathil R; Kusumakumary P; Priyakumary T; Krishnan Nair M
J Exp Clin Cancer Res; 2002 Sep; 21(3):383-8. PubMed ID: 12385582
[TBL] [Abstract][Full Text] [Related]
14. [Karyotypic anomalies and chromosomal sites of increased fragility in colorectal cancer].
Sokova OI; Kirichenko OP; Kulagina OE; Konstantinova LN; Chebotarev AN; Fleĭshman EV
Genetika; 1997 Sep; 33(9):1297-302. PubMed ID: 9445823
[TBL] [Abstract][Full Text] [Related]
15. [The determination of chromosome fragile sites in the peripheral blood lymphocytes of patients with colorectal cancer taking into account the cancer pathology predisposition in the familial anamnesis].
Nesina IP; Polishchuk LZ; Oliĭnichenko PI
Tsitol Genet; 2000; 34(1):3-9. PubMed ID: 10808535
[TBL] [Abstract][Full Text] [Related]
16. Investigation of genetic susceptibility to non-small cell lung cancer by fragile site expression.
Tunca B; Cecener G; Gebitekin C; Egeli U; Ediz B; Ercan I
Teratog Carcinog Mutagen; 2002; 22(3):205-15. PubMed ID: 11948631
[TBL] [Abstract][Full Text] [Related]
17. Population cytogenetics of aphidicolin-induced fragile sites.
Tedeschi B; Vernole P; Sanna ML; Nicoletti B
Hum Genet; 1992 Jul; 89(5):543-7. PubMed ID: 1634231
[TBL] [Abstract][Full Text] [Related]
18. The expression of fragile sites in lymphocytes of patients with rectum cancer and their first-degree relatives.
Tunca B; Egeli U; Zorluoğlu A; Yilmazlar T; Yerci O; Kizil A
Cancer Lett; 2000 May; 152(2):201-9. PubMed ID: 10773413
[TBL] [Abstract][Full Text] [Related]
19. Variation in the expression of aphidicolin-induced fragile sites in human lymphocyte cultures.
Craig-Holmes AP; Strong LC; Goodacre A; Pathak S
Hum Genet; 1987 Jun; 76(2):134-7. PubMed ID: 3111974
[TBL] [Abstract][Full Text] [Related]
20. Expression of aphidicolin, FUdR and caffeine-induced fragile sites in lymphocytes of healthy Turkish individuals.
Güven GS; Hacihanefioğlu S; Cenani A
Genetica; 1999; 105(1):109-16. PubMed ID: 10483096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
